Omiz is indicated in adults and children over 1 year of age and > 10kg.
Omiz gastro-resistant capsules are indicated in:
Adults:
– Treatment of duodenal ulcers
– Prevention of relapse of duodenal ulcers
– Treatment of gastric ulcers
– Prevention of relapse of gastric ulcers
– In combination with appropriate antibiotics, helicobacter pylori (h. Pylori) eradication in peptic ulcer disease
– Treatment of nsaid associated gastric and duodenal ulcers
– Prevention of nsaid associated gastric and duodenal ulcers in patients at risk
– Treatment of reflux esophagitis
– Long term management of patients with healed reflux esophagitis
– Treatment of symptomatic gastro-esophageal reflux disease
– Treatment of zollinger-ellison syndrome
Paedriatric population:
Children over 1 year of age and >10 kg
– Treatment of reflux esophagitis,
– Symptomatic treatment of heartburn and acid regurgitation in gastro-esophageal reflux disease
Children and adolescents over 4 years of age
– In combination with antibiotics in the treatment of duodenal ulcer caused by H. Pylori
Reviews
There are no reviews yet.